To experience the full functionality of this website, cookies are needed. Please activate cookies and refresh your browser. After the refresh, a cookie management dialogue will be shown.

This website uses cookies for reasons of functionality, comfort, and statistics. You can change this setting at any time by clicking on “change settings”. If you consent to this use of cookies, please click “Yes, I agree”. Our privacy policy

 

News from GMP Area

Opened laptop and a hand
Content

End of transition period for the DIN EN ISO 13485:2016, 28th of February 2018

On 15th of January 2018 DAkkS announced the end of the transition period for DIN EN ISO 13485:2016 for 31th of March 2019. It refers to the information for EN ISO 13485:2016 given in the list of harmonized standards under Directive 93/42/EEC for medical devices, which was published in the Official Journal of the European Union on 17th of November 2017. The European Standards Commission has set the withdrawal of EN ISO 13485:2012 to 31th of March 2019 and thus defined the entry into force of EN ISO 13485:2016.

This means that all certificates must be converted to EN ISO 13485:2016 by this date. Certificates that have not been converted lose their validity.

The new revision of the standard includes a number of changes that bring it closer to the American 21 CFR820 (Quality System Regulation) standard. Requirements of the Notified Bodies out of the NBOG and MEDDEV documents have been implemented now. The standard can now also be used by companies operating as service provider or supplier for the medical technology industry.

Up to now, EN ISO 9001 and EN ISO 13485 were very similar in their structure. Due to the new "high level structure" of EN ISO 9001, which has been defined by ISO/IEC for management standards, the two standards now differ, because EN ISO 13485 remains unchanged from the previous structure, a few exceptions excluded.

Valicare GmbH experts offers comprehensive service for the conversion to the EN ISO 13485:2016.

 

Further information


 
Dr Claudia Papewalis is giving a GMP for ATMP training

GMP for ATMPs

If you want to know more about the regulatory requirements requested for manufacturing ATMPs, contact our experts or take part at one of our internal GMP training courses.

A scientist is looking at t-cells visible at a computer screen

GMP-compliant manufacturing process

Valicare supports start-ups like polybiocept in transferring cell-culturing methods developed at the laboratory into a GMP-compliant manufacturing process. Check the press release and get an overview about our GMP for ATMP services.

cell culture, ATMPs

„Guidelines on Good Manufacturing Practice (GMP) specific to Advanced Therapy Medicinal Products”

On 22th of November 2017 the European Commission adopted the "Guidelines on Good Manufacturing Practices (GMP) specific to Advanced Therapy Medicinal Products".